Home Forum Archives Sitemap
Search:
Searching for Cancer Information ...

Archives

Date
  • All
  • Jan
  • Feb
  • Mar
  • Apr
  • May
  • Jun
  • Jul
  • Aug
  • Sep
  • Oct
  • Nov
  • Dec
  • All
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30

Squamous Cell Carcinoma Of The Base Of Tongue Treated With Radiotherapy

Squamous cell carcinoma of the base of tongue could be treated with radiotherapy (RT). Researchers in the United States conducted a study "to evaluate definitive RT for treatment of base of tongue cancer. There were 333 patients with squamous cell carcinoma of the base of tongue treated with definitive RT and had follow-up from .2 to 26.2 years. Follow-up on living patients ranged from 1.2 to 26.2 years (median, 6.6 years)." "Local control rates at 5 years were: T1, 98%; T2, 92%; T3, 82%; and T4, 53%.

Effect Of Antioxidant Vitamins On Reducing Risk Of Lung Cancer Investigated

Scientists investigated the effect of antioxidant vitamins upon reducing the risk of lung cancer. According to a recent article published in the journal Current Pharmaceutical Design, "Tobacco use is the leading risk factor for lung cancer, yet in addition to smoking habit, diet may also play a role in the disease's appearance.

Findings In Cancer Gene Therapy Provide New Insights

Reports from the United States and Germany highlight recent research on cancer gene therapy. Study 1: According to recent research from the United States, absent in melanoma 2 (AIM2) suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model. "IFN-inducible proteins are known to mediate IFN-directed antitumor effects. The human IFN-inducible protein AIM2 gene encodes a 39-kDa protein, which contains a 200-amino-acid repeat as a signature of HIN-200 family (hematopoietic IFN-inducible nuclear proteins)," wrote I.F. Chen and colleagues, M.D.

Ovarian Cancer Treatment By Treosulfan And Carboplatin Compared

Ovarian cancer treatment by treosulfan and carboplatin was compared. According to recent research from Scotland, "The management of older and unfit women with advanced ovarian cancer requires postoperative chemotherapy but many of these patients are not suitable for high-dose cisplatin-based regimes. Carboplatin has been an easier alternative and can be given in the ambulatory setting." "Historical data suggests that oral alkylating agents to be just effective with similar efficacy.

Site Resources

Recent comments

Cancer Reaearch

Cancer Prevention